Skip to content

Fuyang Yunshu method in the treatment of metabolic syndrome: A prospective randomized controlled study

Fuyang Yunshu method in the treatment of metabolic syndrome: A prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081851
Enrollment
Unknown
Registered
2024-03-13
Start date
2023-09-01
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of metabolic syndrome; ? Patients with carotid intima-media thickness =1.0mm without clinical diagnosis of atherosclerotic disease; ? Aged 18-80 years old; ? Conforming to abdominal obesity: waist circumference =90cm for men and =85cm for women; Or BIM=25kg/m2; ? In accordance with the TCM syndrome of spleen and kidney Yang deficiency, dampness and blood stasis; ? Willing to obey the doctor's treatment plan and cooperate with follow-up, and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Patients with definite diagnosis of atherosclerotic disease, including coronary heart disease, stroke, peripheral vascular disease, renal artery stenosis, etc.; ? Patients with heart failure (NYHA class III or above) and severe arrhythmia (persistent rapid atrial fibrillation, atrial flutter, frequent premature ventricular contraction, ventricular tachycardia, atrioventricular block > second degree); ? Complicated with severe primary diseases of liver, kidney, blood system, respiratory system; Hepatic and renal insufficiency (creatinine clearance < 30ml/min, alanine aminotransferase =2.5 times upper limit of normal, total bilirubin =1.5 times upper limit of normal); Or patients with malignant tumors; ? Patients with acute infection; ? Pregnant or lactating women; ? The mentally ill person cannot understand the nature, scope and possible results of the study or cannot comply with the doctor's advice; Or are taking part in other similar interventions; ? Secondary abnormal blood lipids, blood pressure and blood glucose; Type 1 diabetes mellitus; ? Taking corticosteroids, contraceptives, weight loss drugs and other drugs affecting weight.

Design outcomes

Primary

MeasureTime frame
Carotid intima-media thickness;

Secondary

MeasureTime frame
Weight;Fasting blood-glucose;Postprandial blood sugar;Glycosylated hemoglobin;Blood pressure;Blood fat;HOMA-IR;Body fat rate;Hemorheology;Abdominal ultrasonography;TCM main symptom score;Clinical Global Impression Scale;EQ-5D Health Index scale;

Countries

China

Contacts

Public ContactQiyun Lu

Fangcun Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

13751801250@126.com+86 137 5180 1250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026